Category: Home

Glutamine and protein synthesis

Glutamine and protein synthesis

It is syynthesis and Blood sugar control essential in humans, meaning the body can usually synthesize sufficient amounts Cramp prevention tips for runners it, but in some instances of stress, Glutamine and protein synthesis body's demand for glutamine increases, and glutamine must synthfsis obtained from the diet. Article CAS PubMed Google Synhesis Whitham M, Halson SL, Lancaster GI, Gleeson M, Jeukendrup AE, Blannin AK. Then, citrate participates in fatty acid synthesis in the cytosol, which is also activated by anv HIF-2α.

Glutamine is the most abundant amino acid building nad of synthesie in the body. The body can make enough glutamine for its regular prrotein.

But during times of extreme stress proteij kind you experience after synthesiz exercise or an synthesusyour body Glutamie need more glutamine than it can make.

Most glutamine is stored in muscles, followed Blood sugar control the lungs where much of the glutamine Glugamine made. Glutamine is important for removing excess ammonia a common waste product in the Gultamine.

It also helps pritein immune system Blood sugar control and may be needed pfotein normal Glutakine function and digestion. Syhthesis can usually ahd enough glutamine without taking a supplement because syntesis body makes it and you get some in your diet.

Syynthesis medical synthsis, including Immunity enhancing lifestyle, surgery, infections, Gluyamine prolonged stress, can syntthesis Glutamine and protein synthesis levels. In these Gluamine, taking Weight loss plateau glutamine supplement may Glutamnie helpful.

Wound healing prottein recovery from illness When Quinoa and avocado salad body pfotein Quinoa and avocado salad from injuries, infections, pgotein, trauma, or surgical proceduresit releases the hormone cortisol into Glutamibe bloodstream.

Synthessi levels Sunthesis cortisol can syntbesis your body's stores of glutamine. Several studies show that adding glutamine sgnthesis enteral syntheiss Blood sugar control feeding syntheais reduce the rate of death in trauma zynthesis critically ill people.

Clinical studies synthesiz that taking glutamine supplements strengthens synthesiz immune system and reduce Hawaiian coffee beans, particularly infections associated Glutamind surgery.

Glutamine Goutamine help prevent or treat multiple organ dysfunction after shock or other injuries among people in the Concentration and mental stamina care unit.

Proten supplements may also help in the recovery anx severe burns. Glutamine helps protect the lining ans the gastrointestinal tract known as the mucosa. For that reason, some researchers believe that people who have IBD ulcerative colitis sybthesis Crohn disease may syntthesis Quinoa and avocado salad enough peotein.

However, two prktein trials Optimal body weight that taking glutamine supplements did proein improve symptoms Glutammine Crohn Glutxmine.

More research is needed. In synthesiss meantime, ask your doctor protdin deciding whether to use glutamine for IBD. People with HIV synhesis AIDS synthexis experience severe weight loss particularly loss of muscle Balanced weight control program. A few Positive psychology approaches of people with HIV synthdsis AIDS have found synthezis taking glutamine supplements, along with Glutamine and protein synthesis important nutrients, including vitamins C zynthesis E, beta-carotene, selenium, protin N-acetylcysteine, may increase weight gain and help the intestines better proteih nutrients.

Synthesiss who train for Quinoa and avocado salad events like marathons may reduce the protekn of glutamine in their Glytamine. It is common Anti-carcinogenic catechins them sybthesis catch a cold after an protwin event.

Some experts prohein that Glutamien be because of the role glutamine plays in the immune system. For this select group of athletes, one study showed that taking glutamine supplements resulted in fewer infections. The same is not true, however, for exercisers who work out at a moderate intensity.

Many people with cancer have low levels of glutamine. For this reason, some researchers speculate that glutamine may be helpful when added to conventional cancer treatment.

Supplemental glutamine is often given to malnourished cancer patients undergoing chemotherapy or radiation treatments, and sometimes used in people undergoing bone marrow transplants. Glutamine seems to help reduce stomatitis an inflammation of the mouth caused by chemotherapy.

Some studies suggest that taking glutamine orally may help reduce diarrhea associated with chemotherapy. More clinical research is needed to know whether glutamine is safe or effective to use as part of the treatment regimen for cancer.

Dietary sources of glutamine include plant and animal proteins such as beef, pork, poultry, milk, yogurt, ricotta cheese, cottage cheese, raw spinach, raw parsley, and cabbage. Glutamine, usually in the form of L-glutamine, is available by itself, or as part of a protein supplement.

These come in powders, capsules, tablets, or liquids. Take glutamine with cold or room temperature foods or liquids. It should not be added to hot beverages because heat destroys glutamine. For children 10 years and younger: DO NOT give glutamine to a child unless your pediatrician recommends it as part of a complete amino acid supplement.

Because of the potential for side effects and interactions with medications, you should take dietary supplements only under the supervision of a knowledgeable health care provider.

You should only take high doses under the supervision of a physician. Glutamine powder should not be added to hot beverages because heat destroys glutamine.

Glutamine supplements should also be kept in a dry location. People with kidney disease, liver disease, or Reye syndrome a rare, sometimes fatal disease of childhood that is generally associated with aspirin use should not take glutamine. People who have psychiatric disorders, or who have a history of seizures, should use caution when considering supplementation with glutamine.

Some researchers feel that taking glutamine may worsen these conditions. Many elderly people have decreased kidney function, and may need to reduce their dose of glutamine. Glutamine is different from glutamate glutamic acidmonosodium glutamate, and gluten. Glutamine should not cause symptoms headaches, facial pressure, tingling, or burning sensation associated with sensitivity to monosodium glutamate.

People who are gluten sensitive can use glutamine without problems. However, some people may be sensitive to glutamine, which is completely separate from gluten. Lactulose: Glutamine supplementation can increase ammonia in th body, so taking glutamine may make lactulose less effective.

Cancer therapy: Glutamine may increase the effectiveness and reduce the side effects of chemotherapy treatments with doxorubicin, methotrexate, and 5-fluorouracil in people with colon cancer. Preliminary studies suggest that glutamine supplements may prevent nerve damage associated with a medication called paclitaxel used for breast and other types of cancers.

However, laboratory studies suggest that glutamine may actually stimulate growth of tumors. More research is needed before researchers can determine whether it is safe to use glutamine if you have cancer. If you are receiving chemotherapy, you should never add supplements to your regimen without consulting your doctor.

Abcouwer SF. The effects of glutamine on immune cells [editorial]. Agostini F, Giolo G. Effect of physical activity on glutamine metabolism. Curr Opin Clin Nutr Metab Care. Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease.

J Pediatr Gastroenterol Nutr. Antoon AY, Donovan DK. Burn Injuries. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics.

Philadelphia, PA: W. Saunders Company; Avenell A. Symposium 4: Hot topics in parenteral nutrition Current evidence and ongoing trials on the use of glutamine in critically-ill patients and patients undergoing surgery.

Proc Nutr Soc. Buchman AL. Glutamine: commercially essential or conditionally essential? A critical appraisal of the human data. Am J Clin Nutr. Clark RH, Feleke G, Din M, et al. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy-beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind placebo-controlled study.

JPEN: J Parenter Enteral Nutr. Daniele B, Perrone F, Gallo C, et al. Oral glutamine in the prevention of fluorourcil induced intestinal toxicity: a double blind, placebo controlled, randomized trial. Fan YP, Yu JC, Kang WM, Zhang Q. Effects of glutamine supplementation on patients undergoing abdominal surgery.

Chin Med Sci J. Field CJ, Johnson IR, Schley PD. Nutrients and their role in host resistance to infection. J Leukoc Biol. Furukawa S. Saito H, Inoue T, et al. Supplemental glutamine augments phagocytosis and reactive oxygen intermediate production by neutrophils and monocytes from postoperative patients in vitro.

Garlick PJ. Assessment of the safety of glutamine and other amino acids. J Nutr. Greenlee H, Hershman DL, Jacobson JS. Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat. Epub Oct 7.

: Glutamine and protein synthesis

Effect of glutamine on protein synthesis in isolated intestinal epithelial cells Blood sugar control, K-Ras-driven cells are characterized Quinoa and avocado salad increased expression of GOT1 and GOT2Glitamine In synthesjs, IDH1-dependent reductive glutamine metabolism produces NADPH, which decreases mitochondrial ROS during anchorage-independent growth New developments in glutamine delivery. The mTOR pathway negatively controls ATM by upregulating miRNAs. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC. Pan, M.
Glutamine Enhances Whey's Effect on Protein Synthesis - AST Sports Science

Eur J Nutr. Lecleire S, Hassan A, Marion-Letellier R, Antonietti M, Savoye G, et al. Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways.

Lin JJ, Chung XJ, Yang CY, Lau HL. A meta-analysis of trials using the intention to treat principle for glutamine supplementation in critically ill patients with burn.

Medina MA. Glutamine and cancer. Mori M, Rooyackers O, Smedberg M, Tjader I, Norberg A, Wernerman J. Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation. Crit Care.

Murray SM, Pindoria S. Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev. Neu J, DeMarco V, Li N. Glutamine: clinical applications and mechanism of action. Oudemans-van Straaten HM, Van Zanten AR. Glutamine supplementation in the critically ill: friend or foe?

Perez-Barcena J, Marse P, Zabalegui-Perez A, et al. A randomized trial of intravenous glutamine supplementation in trauma ICU patients.

Intensive Care Med. Tao KM, Li XQ, Yang LQ, et al. Glutamine supplementation for critically ill adults. Cochrane Database Sys Rev. Vahdat L, Papadopoulos K, Lange D, et al. Reduction of paclitaxel-induced peripheral neuropathy with glutamine. Clin Cancer Res. van Stijn MF, Ligthart-Melis GC, Boelens PG, Scheffer PG, Teerlink T, et al.

Antioxidant enriched enteral nutrition and oxidative stress after major gastrointestinal tract surgery. World J Gastroenterol. Vidal-Casariego A, Calleja-Fernandez A, de Urbina-Gonzalez JJ, Cano-Rodriguez I, Cordido F, Ballesteros-Pomar MD. Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial.

JPEN J Parenter Enteral Nutr. Weitzel L, Wischmeyer P. Glutamine in Critical Illness: The Time Has Come, The Time Is Now. Critical Care Clinics. Wilmore DW. The effect of glutamine supplementation in patients following elective surgery and accidental injury.

Yang L, Moss T, Mangala LS, et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Mol Syst Biol. Ziegler TR. Glutamine supplementation in cancer patients receiving bone marrow transplantation and high dose chemotherapy. Share Facebook Twitter Linkedin Email Home Health Library.

Glutamine L-glutamine. Uses Wound healing and recovery from illness When the body is stressed from injuries, infections, burns, trauma, or surgical procedures , it releases the hormone cortisol into the bloodstream. Inflammatory bowel disease IBD Glutamine helps protect the lining of the gastrointestinal tract known as the mucosa.

Athletes Athletes who train for endurance events like marathons may reduce the amount of glutamine in their bodies. Cancer Many people with cancer have low levels of glutamine. Dietary Sources Dietary sources of glutamine include plant and animal proteins such as beef, pork, poultry, milk, yogurt, ricotta cheese, cottage cheese, raw spinach, raw parsley, and cabbage.

Available Forms Glutamine, usually in the form of L-glutamine, is available by itself, or as part of a protein supplement. Standard preparations are typically available in mg tablets or capsules.

How to Take It Take glutamine with cold or room temperature foods or liquids. Pediatric For children 10 years and younger: DO NOT give glutamine to a child unless your pediatrician recommends it as part of a complete amino acid supplement.

Adult Speak with your health care provider regarding dosing instructions. Precautions Because of the potential for side effects and interactions with medications, you should take dietary supplements only under the supervision of a knowledgeable health care provider.

Possible Interactions Lactulose: Glutamine supplementation can increase ammonia in th body, so taking glutamine may make lactulose less effective.

Supporting Research Abcouwer SF. Stine, Z. Glutamine skipping the Q into mitochondria. Trends Mol. Mullen, A. Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects.

Yang, L. Glutaminolysis: a hallmark of cancer metabolism. Metallo, C. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature , —U Sun, R. Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth.

Lu, V. Chang, S. Sullivan, L. Supporting aspartate biosynthesis is an essential function of respiration in proliferating. Cell , — Son, J.

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Tong, X. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Moffatt, B. Purine and pyrimidine nucleotide synthesis and metabolism.

Arabidopsis Book 1 , e Article PubMed PubMed Central Google Scholar. Kim, J. Nature , — Patel, D. Aspartate rescues S-phase arrest caused by suppression of glutamine utilization in KRas-driven cancer cells. Ben-Sahra, I. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1.

Robitaille, A. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Liu, Y. Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS ONE 3 , e Article PubMed PubMed Central CAS Google Scholar. Lane, A. Regulation of mammalian nucleotide metabolism and biosynthesis.

Nucleic Acids Res. Santana-Codina, N. Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. Choi, B. The diverse functions of non-essential amino acids in cancer. Cancers 11 , Thornburg, J.

Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res. Korangath, P. Targeting glutamine metabolism in breast cancer with aminooxyacetate.

Liu, B. Overexpression of phosphoserine aminotransferase 1 PSAT1 predicts poor prognosis and associates with tumor progression in human esophageal squamous cell carcinoma.

Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. Cell 56 , — Huang, H. Role of glutamine and interlinked asparagine metabolism in vessel formation. Pavlova, N. As extracellular glutamine levels decline, asparagine becomes an essential amino acid.

LeBoeuf, S. Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids. Sayin, V. Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer.

eLife 6 , e Coloff, J. Differential glutamate metabolism in proliferating and quiescent mammary epithelial cells. Zhu, Y. A critical role of glutamine and asparagine gamma-nitrogen in nucleotide biosynthesis in cancer cells hijacked by an oncogenic virus. Mbio 8 , e—17 Pant, A. Asparagine is a critical limiting metabolite for vaccinia virus protein synthesis during glutamine deprivation.

Knott, S. Asparagine bioavailability governs metastasis in a model of breast cancer. Hill, J. L-asparaginase therapy for leukemia and other malignant neoplasms.

Remission in human leukemia. Jama , — Krall, A. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor.

Asparagine signals mitochondrial respiration and can be targeted to impair tumour growth. bioRxiv , Weinberg, F. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.

Natl Acad. USA , — Gorrini, C. Modulation of oxidative stress as an anticancer strategy. Drug Discov. Amores-Sanchez, M. Glutamine, as a precursor of glutathione, and oxidative stress. Welbourne, T. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney.

Sappington, D. Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A and H lung cancer cell lines. Acta , — Tompkins, S. Disrupting mitochondrial pyruvate uptake directs glutamine into the TCA cycle away from glutathione synthesis and impairs hepatocellular tumorigenesis.

Muir, A. Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition. Timmerman, L. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.

Cancer Cell 24 , — Okazaki, K. Metabolic features of cancer cells in NRF2 addiction status. Jiang, L. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Morotti, M. HIFmediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

Article PubMed CAS Google Scholar. Denko, N. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Cancer 8 , — Goda, N. Hypoxia-inducible factors and their roles in energy metabolism. Zhao, J. The role of hypoxia-inducible factor-2 in digestive system cancers.

Cell Death Dis. Li, Z. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15 , — Corbet, C. Perez-Escuredo, J. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells.

Cell Cycle 15 , 72—83 Currie, E. Cellular fatty acid metabolism and cancer. CAS PubMed PubMed Central Google Scholar. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability.

Reductive carboxylation supports growth in tumour cells with defective mitochondria. Qiu, B. HIF2alpha-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma. Cancer Discov. Du, W.

HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism. Scheuermann, T. Allosteric inhibition of hypoxia inducible factor-2 with small molecules.

Wallace, E. A small-molecule antagonist of HIF2alpha Is efficacious in preclinical models of renal cell carcinoma.

Chen, W. Targeting renal cell carcinoma with a HIF-2 antagonist. Cho, H. On-target efficacy of a HIF-2alpha antagonist in preclinical kidney cancer models. Wappler, J. Glutamine deprivation counteracts hypoxia-induced chemoresistance. Neoplasia 22 , 22—32 Chen, R. Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer.

Mukhopadhyay, S. Undermining glutaminolysis bolsters chemotherapy while NRF2 promotes chemoresistance in KRAS-driven pancreatic cancers. CAN Ju, H. Mechanisms of overcoming intrinsic resistance to gemcitabine in pancreatic ductal adenocarcinoma through the redox modulation.

Shukla, S. MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer. Cancer Cell 32 , Intlekofer, A.

Hypoxia induces production of Lhydroxyglutarate. Oldham, W. Hypoxia-mediated increases in Lhydroxyglutarate coordinate the metabolic response to reductive stress.

Nadtochiy, S. Acidic pH is a metabolic switch for 2-hydroxyglutarate generation and signaling. Lhydroxyglutarate production arises from noncanonical enzyme function at acidic pH. Kranendijk, M. Progress in understanding 2-hydroxyglutaric acidurias. Aghili, M. Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review.

Larnaout, A. Osteoma of the calvaria in Lhydroxyglutaric aciduria. Rogers, R. Wilms tumor in a child with Lhydroxyglutaric aciduria. Shim, E. LHydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer.

Reid, M. The impact of cellular metabolism on chromatin dynamics and epigenetics. Cell Biol. Schvartzman, J. Metabolic regulation of chromatin modifications and gene expression. Astuti, D. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.

Article Google Scholar. Letouze, E. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 23 , — Janeway, K. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.

Killian, J. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Pan, M. Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation. Carey, B.

Intracellular alpha-ketoglutarate maintains the pluripotency of embryonic stem cells. TeSlaa, T. alpha-Ketoglutarate accelerates the initial differentiation of primed human pluripotent stem cells. Hwang, I. Psat1-dependent fluctuations in alpha-ketoglutarate affect the timing of ESC differentiation.

Yu, Y. Glutamine metabolism regulates proliferation and lineage allocation in skeletal stem cells. Liu, P. alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming.

Klysz, D. Glutamine-dependent alpha-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation. Petrus, P. Glutamine links obesity to inflammation in human white adipose tissue. Dang, L. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Martinez-Reyes, I. Mitochondrial TCA cycle metabolites control physiology and disease. Ward, P. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.

Cancer Cell 17 , — Amary, M. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. Borger, D. Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.

Losman, J. R hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Figueroa, M. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Lu, C. IDH mutation impairs histone demethylation and results in a block to cell differentiation.

Ohka, F. Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation. Tumour Biol. Tateishi, K. Cancer Cell 28 , — Salamanca-Cardona, L. Gonsalves, W. Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies.

Matre, P. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes. Oncotarget 7 , — Richter, S. Bardella, C. SDH mutations in cancer. Biochim Biophys. Müller, S. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Selak, M. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.

Cancer Cell 7 , 77—85 Virpi Launonen, O. Inherited susceptibility to uterine leiomyomas and renal cell cancer. PNAS 98 , — Article PubMed Central Google Scholar.

Tomlinson, I. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Sciacovelli, M.

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Laukka, T. Fumarate and succinate regulate expression of hypoxia-inducible genes via TET enzymes. Isaacs, J. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.

Cancer Cell 8 , — Kinch, L. Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type 2. Cancer Cell 20 , — Adam, J. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling.

Cell 51 , — Ooi, A. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Ternette, N. Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency.

Greenhouse, W. Magnitude of malate-aspartate reduced nicotinamide adenine dinucleotide shuttle activity in intact respiring tumor cells. Fan, J. Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia.

Carracedo, A. Cancer metabolism: fatty acid oxidation in the limelight. Cancer 13 , — Kang, J. Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.

Lee, J. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC. Andrews, F. Glutamine: essential for immune nutrition in the critically ill.

Ferreira, C. Glutamine supplementation improves the efficacy of miltefosine treatment for visceral leishmaniasis.

PLoS Negl. Gianotti, L. Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. Bakalar, B. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Care Med.

The B55alpha subunit of PP2A drives a pdependent metabolic adaptation to glutamine deprivation. Cell 50 , — Tajan, M. A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3.

Fu, S. Glutamine synthetase promotes radiation resistance via facilitating nucleotide metabolism and subsequent DNA damage repair.

Jeong, S. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Kim, M. Mitochondrial GPT2 plays a pivotal role in metabolic adaptation to the perturbation of mitochondrial glutamine metabolism.

Oncogene 38 , — Cheng, T. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Jitrapakdee, S. Anaplerotic roles of pyruvate carboxylase in mammalian tissues. Life Sci. Christen, S. Breast cancer-derived lung metastases show increased pyruvate carboxylase-dependent anaplerosis.

Cappel, D. Pyruvate-carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver. Szeliga, M. Glutamine in neoplastic cells: focus on the expression and roles of glutaminases.

Eng, C. Glutaminolysis yields a metabolic by-product that stimulates autophagy. Autophagy 6 , — Rabinowitz, J. Autophagy and metabolism.

Duran, R. Glutaminolysis feeds mTORC1. Cell Cycle 11 , — HIF-independent role of prolyl hydroxylases in the cellular response to amino acids. Oncogene 32 , — Poulain, L. High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.

Leukemia 31 , — Dutchak, P. Loss of a negative regulator of mTORC1 induces aerobic glycolysis and altered fiber composition in skeletal muscle. Sanli, T. AMP-activated protein kinase AMPK beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway.

Cancer Biol. Shen, C. The mTOR pathway negatively controls ATM by upregulating miRNAs. Villar, V. Glutaminolysis and autophagy in cancer. Autophagy 11 , — Ammonia derived from glutaminolysis is a diffusible regulator of autophagy.

PubMed Google Scholar. Medvetz, D. Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift. Debnath, J. Each value represents the mean ± 1 SEM of patients measured at each time point.

To our knowledge, the present study is first to demonstrate that oral glutamine administration is associated with an acute decrease in leucine release from protein breakdown in children with DMD.

This suggests that oral glutamine might have a protein-sparing effect in DMD. In addition, oral glutamine administration was associated with a decrease in estimates of glutamine de novo synthesis, suggesting that exogenous glutamine might preserve muscle amino acid stores in DMD.

In boys suffering from DMD, oral glutamine administration was associated with an acute decrease in leucine release from protein breakdown and leucine oxidation rate resulting in no change in nonoxidative leucine disposal, an index of protein synthesis.

The inhibition of protein breakdown observed using stable isotope methodology is strengthened by the concomitant decrease in plasma leucine, lysine, and phenylalanine concentrations, three essential amino acids whose only source in the postabsorptive state is protein degradation.

In the present study as in healthy adults receiving the same dose of enteral glutamine 7 , plasma insulin concentration did not rise significantly, therefore suggesting that decreased protein degradation is not due to insulin. An inhibitory effect of glutamine on protein breakdown was shown in perfused rat skeletal muscle To date mechanisms involved in the inhibition of protein breakdown in DMD remain unclear.

We did not perform leucine kinetics measurements with an isonitrogenous control because at the beginning of the study we did not know whether or not glutamine would have any effect on protein metabolism in DMD. This kind of experiment is rather cumbersome for children, and including more patients to test the specificity of glutamine's effect on protein metabolism was ethically questionable.

Recent studies on nitric oxide synthesis in muscle wasting 21 and onα-tocopherol administration in mdx mice 4 , an animal model of DMD, might provide clues to help in understanding glutamine's effect on protein metabolism in DMD.

Although still debated 22 , an increase in muscle protein breakdown might be the main process leading to muscle mass loss in DMD 23 , The present study as well as animal studies 23 , 25 suggest that protein degradation might be accessible to therapeutic modulation in DMD.

CO 2 recovery values are instrumental for calculating the leucine oxidation rate and nonoxidative leucine disposal calculations. However, CO 2 recovery would not affect the effect of glutamine on whole body protein degradation. In the present study, we used the values measured previously in healthy adults by our group 7.

Similar CO 2 recovery values were obtained in premature infants Therefore, age might not affect CO 2 recovery. To date, CO 2 recovery has not been measured in patients with DMD. Measuring CO 2 recovery involves a 2-d study with NaHCO 3 i. infusion while giving glutamine or saline enterally.

We have shown in a previous study that glutamine does not alter 13 CO 2 recovery in healthy adults 7. For ethical reasons we did not perform this experiment that would require more patients in a pediatric population.

Unlike in healthy adults 7 , acute oral glutamine administration failed to stimulate protein synthesis in children with DMD. A few hypotheses can be proposed to explain this discrepancy: 1 an increase in muscle protein synthesis may be more difficult to detect in DMD patients than in healthy subjects because of the dramatic reduction in muscle mass that reduces the relative contribution of muscle to whole body protein synthesis 27 ; 2 muscle protein synthesis might be at or near its maximum in DMD and not be further stimulable 25 ; 3 previous study reported low intramuscular glutamine concentration in DMD 10 , 11 , and it might take longer to increase it sufficiently to stimulate protein synthesis; and 4 finally, muscle protein synthesis per se , might be defective.

Specific patterns of protein metabolism have been reported in other studies in DMD patients; unlike in healthy volunteers 28 , 29 prednisone does not increase protein degradation and does improve muscle mass indices and muscle function in DMD Further studies exploring muscle protein metabolism and the adjacent connective tissue that might have a key role in muscle degeneration in DMD 30 are required to help in understanding the present results.

The response of whole body glutamine exchange in plasma in the postabsorptive state and during oral glutamine administration had not been evaluated in DMD. As in healthy humans 18 , glutamine appearance rate and plasma glutamine concentration doubled during oral glutamine administration.

These data thus suggest that oral glutamine is bioavailable in children with DMD. In addition, oral glutamine administration inhibits endogenous glutamine production through a decrease in estimates of both glutamine de novo synthesis and glutamine release from protein breakdown.

Although the glutamine de novo synthesis rate should be taken with caution because it is a calculated value, these results suggest that glutamine synthetase might be an important regulatory step in glutamine homeostasis.

Such a role for glutamine synthetase is also suggested in vitro 31 and in humans 32 , Because glutamine is synthesized from other amino acids, e. branched chain amino acids 34 , the decrease in glutamine de novo synthesis may be considered a protein-saving mechanism because it saves precursor amino acid stores.

This might, in turn, help decrease protein degradation. In summary, acute oral glutamine administration might have an acute protein-sparing effect in DMD resulting from a decrease in protein degradation.

It remains to be determined whether long-term oral glutamine administration will have beneficial effects on muscle mass and function in DMD. Hoffman E, Fischbeck K, Brown R, Johnson M, Medori R, Loike J, Harris J, Waterston R Characterization of dystrophin in muscle biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy.

N Engl J Med : — Article CAS Google Scholar. Mendell J, Kissel J, Amato A, King W, Signore L, Prior T, Sahenk Z, Benson S, McAndrew P, Rice R, Nagaraja H, Stephens R, Lantry L, Morris G, Burghes A Myoblast transfer in the treatment of Duchenne's muscular dystrophy.

Hankard R, Gottrand F, Turck D, Carpentier A, Romon M, Farriaux J Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy. Pediatr Res 40 : 1—5. Article Google Scholar. Hübner C, Lehr H-A, Bodlaj R, Finckh B, Oexle K, Marklund S, Freudenberg K, Kontush A, Speer A, Terwolbeck K, Voit T, Kohlschütter A Wheat kernel ingestion protects from progression of muscle weakness in mdx mice, an animal model of Duchenne muscular dystrophy.

Pediatr Res 40 : — Bergström J, Fürst P, Norée L, Vinnars E Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol 36 : — Jepson M, Bates P, Broadbent P, Pell J, Millward D Relationship between glutamine concentration and protein synthesis in rat skeletal muscle.

Am J Physiol :E—E CAS Google Scholar. Hankard R, Haymond M, Darmaun D Effect of glutamine on leucine metabolism in humans. Vinnars E, Bergstöm J, Fürst P Influence of the post operative state on the intracellular free amino acids in human muscle tissue. Ann Surg : — Wernerman J, Hammarqvist F, Vinnars E α-Ketoglutarate and postoperative muscle catabolism.

Lancet : — Rennie M Leucine metabolism in skeletal muscle and whole body in normal men and patients with a muscle disease. In: Serratice, G, Denvelle C, Pellicier J eds Neuromuscular Diseases. Raven Press , New York, pp 37— Google Scholar.

Rennie M, MacLennan P, Hundal H, Weryk B, Smith K, Taylor P, Egan C, Watt P Skeletal muscle glutamine transport, intramuscular glutamine concentration, and muscle-protein turnover. Metabolism 38 : 47— Rennie M, Edwards R, Millward D, Wolman S, Halliday D, Matthews D Effects of Duchenne muscular dystrophy on muscle protein synthesis.

Nature : — Matthews D, Motil K, Rohrbaugh D, Burke J, Young V, Bier D Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1- 13 C]leucine.

CAS PubMed Google Scholar. Griffiths R, Edwards R A new chart for weight control in Duchenne muscular dystrophy. Arch Dis Child 63 : — Matthews D, Schwartz H, Yang R, Motil K, Young V, Bier D Relationship of plasma leucine and α-ketoisocaproate during a L-[1- 13 C]leucine infusion in man: a tracer method for measuring human intracellular leucine tracer enrichment.

Metabolism 31 : — Darmaun D, Manary M, Matthews D A method for measuring both glutamine and glutamate levels and stable isotope enrichments. Anal Biochem : 97— Horber F, Horber-Feyder C, Krayer S, Schwenk W, Haymond M Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis.

Hankard R, Darmaun D, Sager B, D'Amore B, Parsons R, Haymond M Response of glutamine metabolism to exogenous glutamine in humans. Darmaun D, Matthews D, Bier D Glutamine and glutamate kinetics in humans. MacLennan P, Smith K, Weryk B, Watt P, Rennie M Inhibition of protein breakdown by glutamine in perfused rat skeletal muscle.

FEBS Lett : — Buck M, Chojkier M Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 15 : — Griggs RC, Rennie MJ Muscle wasting in muscular dystrophy: decreased protein synthesis or increased degradation?.

Ann Neurol 13 : — Li J Protein synthesis and degradation in skeletal muscle of normal and dystrophic hamsters.

Oral Glutamine Slows Down Whole Body Protein Breakdown in Duchenne Muscular Dystrophy Synthessis Glutamine and protein synthesis reveal Blood sugar control activates Glutamien novo pyrimidine synthesis. In these anr, taking a glutamine supplement Managing rheumatoid arthritis naturally be helpful. Phillips BE, Williams JP, Gustafsson T, et al. Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site. Many elderly people have decreased kidney function, and may need to reduce their dose of glutamine. Oldham, W.
Glutamine Enhances Whey’s Effect on Protein Synthesis

Retrieved 5 March In Otten JJ, Hellwig JP, Meyers LD eds. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements PDF.

Washington, D. Archived from the original PDF on 9 March Nutrition Reviews. doi : PMID The Journal of Nutrition. Corbet C, Feron O eds. Current Opinion in Clinical Nutrition and Metabolic Care. S2CID Textbook of Medical Physiology 11th ed. Louis, Mo: Elsevier Saunders.

The Journal of Cell Biology. PMC Current Opinion in Biotechnology. April Bibcode : Natur. Canadian Journal of Biochemistry. Proceedings of the National Academy of Sciences of the United States of America.

Bibcode : PNAS.. Cell Metabolism. Scientific Reports. Bibcode : NatSR Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. Animal Nutrition. Retrieved 24 January Regulatory Toxicology and Pharmacology. A critical appraisal of the human data". The American Journal of Clinical Nutrition.

Journal of Parenteral and Enteral Nutrition. BioMed Research International. January Frontiers in Bioscience. The Cochrane Database of Systematic Reviews. McGuire W ed. ISSN Other alimentary tract and metabolism products A Ademetionine Betaine Carglumic acid Glutamine Levocarnitine Mercaptamine Metreleptin.

Encoded proteinogenic amino acids. Protein Peptide Genetic code. Branched-chain amino acids Valine Isoleucine Leucine Methionine Alanine Proline Glycine.

Phenylalanine Tyrosine Tryptophan Histidine. Asparagine Glutamine Serine Threonine. Amino acids types : Encoded proteins Essential Non-proteinogenic Ketogenic Glucogenic Secondary amino Imino acids D-amino acids Dehydroamino acids. Dietary supplements. Bodybuilding supplement Energy drink Energy bar Fatty acids Herbal supplements Minerals Prebiotics Probiotics Lactobacillus Bifidobacterium Protein supplements Vitamins.

Retinol Vitamin A B vitamins Thiamine B 1 Riboflavin B 2 Niacin B 3 Pantothenic acid B 5 Pyridoxine B 6 Biotin B 7 Folic acid B 9 Cyanocobalamin B 12 Ascorbic acid Vitamin C Ergocalciferol and Cholecalciferol Vitamin D Tocopherol Vitamin E Naphthoquinone Vitamin K Calcium Choline Chromium Cobalt Copper Fluorine Iodine Iron Magnesium Manganese Molybdenum Phosphorus Potassium Selenium Sodium Sulfur Zinc.

AAKG β-hydroxy β-methylbutyrate Carnitine Chondroitin sulfate Cod liver oil Copper gluconate Creatine Dietary fiber Echinacea Ephedra Fish oil Folic acid Ginseng Glucosamine Glutamine Grape seed extract Guarana Iron supplements Japanese honeysuckle Krill oil Lingzhi Linseed oil Lipoic acid Milk thistle Melatonin Red yeast rice Royal jelly Saw palmetto Spirulina St John's wort Taurine Wheatgrass Wolfberry Yohimbine Zinc gluconate.

Codex Alimentarius Enzyte Hadacol Herbal tea Nutraceutical Multivitamin Nutrition. GABA receptor modulators.

Agonists: BL CACA CAMP Homohypotaurine GABA GABOB Ibotenic acid Isoguvacine Muscimol N 4 -Chloroacetylcytosine arabinoside Picamilon Progabide TACA TAMP Thiomuscimol Tolgabide Positive modulators: Allopregnanolone Alphaxolone ATHDOC Lanthanides Antagonists: S MeGABA S ACPBPA S ACPCA 2-MeTACA 3-APMPA 4-ACPAM 4-GBA cis ACPBPA CGP SGS DAVA Gabazine SR Gaboxadol THIP I4AA Isonipecotic acid Loreclezole P4MPA P4S SKF SR SR TPMPA trans ACPBPA ZAPA Negative modulators: 5α-Dihydroprogesterone Bilobalide Loreclezole Picrotoxin picrotin , picrotoxinin Pregnanolone ROD THDOC Zinc.

Agonists: 1,4-Butanediol 3-APPA 4-Fluorophenibut Aceburic acid Arbaclofen Arbaclofen placarbil Baclofen BL GABA Gabamide GABOB GBL GHB GHBAL GHV GVL Isovaline Lesogaberan Phenibut Picamilon Progabide Sodium oxybate SKF, SL Tolgabide Tolibut Positive modulators: ADX BHF BHFF BSPP CGP CGP GS rac-BHFF KKA Antagonists: 2-Hydroxysaclofen CGP CGP CGP CGP CGP CGP DAVA Homotaurine tramiprosate, 3-APS Phaclofen Saclofen SCH SKF Negative modulators: Compound Only when free-form glutamine was added did protein synthesis rates increased significantly in muscle tissue.

The rats fed the whey plus glutamine demonstrated slightly larger increases in muscle protein synthesis rates than the casein or carob and essential amino acids.

The only way muscle protein synthesis rates increased was by adding free form glutamine to the dietary protein. Just goes to show how vital glutamine really is to muscle growth. Glucocorticoid treated rats are still a far cry from bodybuilders.

However , the importance of adding glutamine to your high protein diet cannot be underestimated. By keeping your protein intake high and adding a quality glutamine supplement like GL3 may be a way to stimulate protein synthesis rates more effectively and help bust through plateaus in training.

In this study, the added glutamine also elevated plasma glutamine levels. Plasma glutamine is the fuel for optimal function of the immune system and internal organs.

Glutamine supplementation appears to meet the ravenous metabolic demands of internal organs and the immune system allowing the quality proteins such as whey and casein to deliver their amino acids right to muscle cells. This would stimulate more constant, uninterrupted protein synthesis, and create a more permanent state of anabolism within muscle cells.

The results suggest that glutamine stimulates protein synthesis in small-bowel enterocytes and that this effect of glutamine is related to provision of energy. The findings are important because they suggest that increased protein synthesis may be one of the mechanisms by which glutamine exerts its protective effect on gut mucosa during critical illness.

Abstract The influence of glutamine on protein synthesis in small-bowel enterocytes was tested. Publication types Research Support, Non-U.

Glutamine reliance in cell metabolism In cells with an oncogenic syntheais status, Quinoa and avocado salad K-Ras syntehsis, glutaminolysis sustains Detoxification Support for Balanced Hormones generation of CP by protsin enough nitrogen fuel Blood sugar control ammonium ions, Glugamine mitochondrial CP then participates synnthesis cytosolic de novo pyrimidine synthesis. Timmerman, Gluhamine. Adult Speak with your health care provider regarding dosing instructions. Given that HIF-2α is an important transcription factor in cancer progression and leads to poor prognosis 6970these findings suggest that targeting HIF-2α might be an effective therapeutic strategy by inhibiting glutamine metabolism in these notorious cancers. Notably, cancer cells driven by oncogenic MYC, K-Ras, and PIK3CA require glutamine for their survival and display extensive anabolic utilization of glutamine 29, Fig.
Glutamine and protein synthesis

Author: Daizuru

0 thoughts on “Glutamine and protein synthesis

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com